KRM Ayurveda IPO
Live Updates, GMP, Subscription Data, and Financial Details
IPO Overview
Listed
Dates
Jan 21 to Jan 23 2026
Price Band
₹128 - 135
Current GMP
₹172.1 (+27.48%)
Subscription
74.27 times
IPO Details
| IPO Date | 21 to 23 Jan, 2026 |
| Listing Date | Thu, Jan 29, 2026 |
| Face Value | ₹ 10 per share |
| Price Band | ₹128 to ₹135 |
| Issue Price | ₹135 per share |
| Lot Size | 1,000 Shares |
| Sale Type | Fresh Capital |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Total Issue Size | 57,40,000 shares (agg. up to ₹ 77 Cr) |
| Reserved for Market Maker | 5,74,000 shares (agg. up to ₹ 8 Cr) Mansi Share & Stock Broking Pvt.Ltd. |
| Net Offered to Public | 51,66,000 shares (agg. up to ₹ 70 Cr) |
| Share Holding Pre Issue | 1,55,20,800 shares |
| Share Holding Post Issue | 2,12,60,800 shares |
| NSE Symbol | KRMAYURVED |
| ISIN | INE1MTV01019 |
IPO Date
21 to 23 Jan, 2026
Listing Date
Thu, Jan 29, 2026
Face Value
₹ 10 per share
Price Band
₹128 to ₹135
Issue Price
₹135 per share
Lot Size
1,000 Shares
Sale Type
Fresh Capital
Issue Type
Bookbuilding IPO
Listing At
NSE SME
Total Issue Size
57,40,000 shares (agg. up to ₹ 77 Cr)
Reserved for Market Maker
5,74,000 shares (agg. up to ₹ 8 Cr) Mansi Share & Stock Broking Pvt.Ltd.
Net Offered to Public
51,66,000 shares (agg. up to ₹ 70 Cr)
Share Holding Pre Issue
1,55,20,800 shares
Share Holding Post Issue
2,12,60,800 shares
NSE Symbol
KRMAYURVED
ISIN
INE1MTV01019
IPO Subscription Details
| Anchor | 1 |
| Market Maker | 1 |
| QIB (Ex Anchor) | 63.31 |
| NII*** | 135.37 |
| bNII (> ₹10L) | 166.53 |
| sNII (< ₹10L) | 73.04 |
| Individual Investors | 54.21 |
| Total ** | 74.27 |
Anchor
1
Market Maker
1
QIB (Ex Anchor)
63.31
NII***
135.37
bNII (> ₹10L)
166.53
sNII (< ₹10L)
73.04
Individual Investors
54.21
Total **
74.27
Day Wise Sub
| Day | QIB (Ex Anchor) | NII* | NII (> ₹10L) | NII (< ₹10L) | Individual Investors | Total |
|---|---|---|---|---|---|---|
| Jan 2 1 (Day 1) | 0.00 | 1.70 | 1.96 | 1.17 | 1.71 | 1.22 |
| Jan 2 2 (Day 2) | 0.00 | 4.44 | 5.15 | 3.03 | 3.68 | 2.80 |
| Jan 2 3 (Day 3) | 63.31 | 135.37 | 166.53 | 73.04 | 54.21 | 74.27 |
DayJan 2
1 (Day 1)
QIB (Ex Anchor)0.00
NII*1.70
NII (> ₹10L)1.96
NII (< ₹10L)1.17
Individual Investors1.71
Total1.22
DayJan 2
2 (Day 2)
QIB (Ex Anchor)0.00
NII*4.44
NII (> ₹10L)5.15
NII (< ₹10L)3.03
Individual Investors3.68
Total2.80
DayJan 2
3 (Day 3)
QIB (Ex Anchor)63.31
NII*135.37
NII (> ₹10L)166.53
NII (< ₹10L)73.04
Individual Investors54.21
Total74.27
Day Wise GMP
| Date | Price | GMP | Estimate List Price |
|---|---|---|---|
| 29-01-2026 | 135.00 | 22.5(16.67%) | 157.5 |
| 28-01-2026 | 135.00 | 22.5(16.67%) | 157.5 |
| 27-01-2026 | 135.00 | 20(14.81%) | 155 |
| 26-01-2026 | 135.00 | 19(14.07%) | 154 |
| 25-01-2026 | 135.00 | 17(12.59%) | 152 |
| 24-01-2026 | 135.00 | 17(12.59%) | 152 |
| 23-01-2026 | 135.00 | 17(12.59%) | 152 |
| 22-01-2026 | 135.00 | 16(11.85%) | 151 |
| 21-01-2026 | 135.00 | 12(8.89%) | 147 |
| 20-01-2026 | 135.00 | 21(15.56%) | 156 |
| 19-01-2026 | 135.00 | 20(14.81%) | 155 |
| 18-01-2026 | 135.00 | 20(14.81%) | 155 |
| 17-01-2026 | 135.00 | 20(14.81%) | 155 |
| 16-01-2026 | 135.00 | 18(13.33%) | 153 |
| 15-01-2026 | 135.00 | 15(11.11%) | 150 |
| 14-01-2026 | 135.00 | 0(%) | (%) |
Date29-01-2026
Price135.00
GMP22.5(16.67%)
Estimate List Price157.5
Date28-01-2026
Price135.00
GMP22.5(16.67%)
Estimate List Price157.5
Date27-01-2026
Price135.00
GMP20(14.81%)
Estimate List Price155
Date26-01-2026
Price135.00
GMP19(14.07%)
Estimate List Price154
Date25-01-2026
Price135.00
GMP17(12.59%)
Estimate List Price152
Date24-01-2026
Price135.00
GMP17(12.59%)
Estimate List Price152
Date23-01-2026
Price135.00
GMP17(12.59%)
Estimate List Price152
Date22-01-2026
Price135.00
GMP16(11.85%)
Estimate List Price151
Date21-01-2026
Price135.00
GMP12(8.89%)
Estimate List Price147
Date20-01-2026
Price135.00
GMP21(15.56%)
Estimate List Price156
Date19-01-2026
Price135.00
GMP20(14.81%)
Estimate List Price155
Date18-01-2026
Price135.00
GMP20(14.81%)
Estimate List Price155
Date17-01-2026
Price135.00
GMP20(14.81%)
Estimate List Price155
Date16-01-2026
Price135.00
GMP18(13.33%)
Estimate List Price153
Date15-01-2026
Price135.00
GMP15(11.11%)
Estimate List Price150
Date14-01-2026
Price135.00
GMP0(%)
Estimate List Price(%)
IPO Important Dates
| IPO Open | Wed, Jan 21, 2026 |
| IPO Close | Fri, Jan 23, 2026 |
| Allotment | Tue, Jan 27, 2026 |
| Refund | Wed, Jan 28, 2026 |
| Credit of Shares | Wed, Jan 28, 2026 |
| Listing | Thu, Jan 29, 2026 |
IPO Open
Wed, Jan 21, 2026
IPO Close
Fri, Jan 23, 2026
Allotment
Tue, Jan 27, 2026
Refund
Wed, Jan 28, 2026
Credit of Shares
Wed, Jan 28, 2026
Listing
Thu, Jan 29, 2026
IPO Lot Size
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 2,000 | ₹2,70,000 |
| Individual investors (Retail) (Max) | 2 | 2,000 | ₹2,70,000 |
| S-HNI (Min) | 3 | 3,000 | ₹4,05,000 |
| S-HNI (Max) | 7 | 7,000 | ₹9,45,000 |
| B-HNI (Min) | 8 | 8,000 | ₹10,80,000 |
ApplicationIndividual investors (Retail) (Min)
Lots2
Shares2,000
Amount₹2,70,000
ApplicationIndividual investors (Retail) (Max)
Lots2
Shares2,000
Amount₹2,70,000
ApplicationS-HNI (Min)
Lots3
Shares3,000
Amount₹4,05,000
ApplicationS-HNI (Max)
Lots7
Shares7,000
Amount₹9,45,000
ApplicationB-HNI (Min)
Lots8
Shares8,000
Amount₹10,80,000
Key Performance Indicator
| ROE | 21.84% |
| ROCE | 21.84% |
| Debt/Equity | 0.69 |
| RoNW | 21.84% |
| PAT Margin | 16.83% |
| EBITDA Margin | 26.54% |
| Price to Book Value | 5.27 |
ROE
21.84%
ROCE
21.84%
Debt/Equity
0.69
RoNW
21.84%
PAT Margin
16.83%
EBITDA Margin
26.54%
Price to Book Value
5.27
Peers Comparison
| Company Name | EPS (Basic) | EPS (Diluted) | NAV (₹ per share) | P/E (x) | RoNW (%) | P/BV Ratio |
|---|---|---|---|---|---|---|
| KRM Ayurveda Ltd. | 5.24 | 5.24 | 25.64 | 27.13 | ||
| Jeena Sikho Lifecare Limited | 8.86 | 8.86 | 142.24 | 76.58 | 31.28 | 4.77 |
| Vaidya Sane Ayurved Laboratories Limited | 3.07 | 3.07 | 59.85 | 93.20 | 5.12 | 4.85 |
Company NameKRM Ayurveda Ltd.
EPS (Basic)5.24
EPS (Diluted)5.24
NAV (₹ per share)25.64
P/E (x)
RoNW (%)27.13
P/BV Ratio
Company NameJeena Sikho Lifecare Limited
EPS (Basic)8.86
EPS (Diluted)8.86
NAV (₹ per share)142.24
P/E (x)76.58
RoNW (%)31.28
P/BV Ratio4.77
Company NameVaidya Sane Ayurved Laboratories Limited
EPS (Basic)3.07
EPS (Diluted)3.07
NAV (₹ per share)59.85
P/E (x)93.20
RoNW (%)5.12
P/BV Ratio4.85
IPO Reservation
| Market Maker Shares Offered | 5,74,000 (10.00%) |
| QIB Shares Offered | 25,74,000 (44.84%) |
| − Anchor Investor Shares Offered | 15,42,000 (26.86%) |
| − QIB (Ex. Anchor) Shares Offered | 10,32,000 (17.98%) |
| NII (HNI) Shares Offered | 7,80,000 (13.59%) |
| − bNII > ₹10L | 5,20,000 (9.06%) |
| − sNII < ₹10L | 2,60,000 (4.53%) |
| Retail Shares Offered | 18,12,000 (31.57%) |
| Total Shares Offered | 57,40,000 (100.00%) |
Market Maker Shares Offered
5,74,000 (10.00%)
QIB Shares Offered
25,74,000 (44.84%)
− Anchor Investor Shares Offered
15,42,000 (26.86%)
− QIB (Ex. Anchor) Shares Offered
10,32,000 (17.98%)
NII (HNI) Shares Offered
7,80,000 (13.59%)
− bNII > ₹10L
5,20,000 (9.06%)
− sNII < ₹10L
2,60,000 (4.53%)
Retail Shares Offered
18,12,000 (31.57%)
Total Shares Offered
57,40,000 (100.00%)
Information about company
Incorporated on 3 September 2019, KRM Ayurveda Ltd. is operating a network of hospitals and clinics across multiple cities in India as well as marked its presence in abroad through telemedicines consulting and sales.
They manufacture Ayurvedic products, herbal and botanical remedies, medicines, supplements and possibly skin care / wellness related items.
Presently, the company runs 6 (Six) Hospitals and 5 (Five) Clinics at different locations in the country.
Hospitals and Clinics are equipped with the following infrastructure & facilities:
Services:
As on December 31, 2025, the company have total of 443 employees operating under various departments.
Competitive Strengths:
Objectives of IPO
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Capital Expenditure for Construction and Development of Telemedicine Operational Facilities 13.67 2 Purchase of CRM Software and Hardware Infrastructure 1.42 3 Human Resources 5.44 4 Repayment/Prepayment of loan 12.50 5 Working Capital Requirement 22.90 6 General Corporate Purposes
Disclaimer
All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions.
We are not a SEBI Registered analyst. Readers must consult a qualified financial advisor prior to making any actual investment decisions, based on Information published on this application.
No financial information whatsoever published anywhere, within this application, should be considered as advice to buy or sell securities or invest in IPOs, or as a guide to doing so in any way whatsoever
Please read all Tearms and conditions , and agree to use the App